Published in N Engl J Med on December 21, 1978
Growth and childhood asthma. Arch Dis Child (1986) 2.28
Growth of asthmatic children during treatment with budesonide: a double blind trial. BMJ (1991) 1.85
Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J (Clin Res Ed) (1986) 1.49
Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma. Arch Dis Child (1993) 1.14
Inhaled corticosteroid therapy in children: an assessment of the potential for side effects. Thorax (1994) 1.08
Effects of high doses of inhaled corticosteroids on adrenal function in children with severe persistent asthma. Thorax (1993) 1.05
The recent history of the treatment of asthma: a personal view. Thorax (1983) 0.88
Combined oral and nasal beclomethasone diproprionate in children with atopic eczema: a randomised controlled trial. Br Med J (Clin Res Ed) (1984) 0.88
Control of asthma. Can Med Assoc J (1982) 0.86
Naloxone and weight reduction: an exercise in introspection. Trans Am Clin Climatol Assoc (1981) 0.75
Perioperative respiratory assessment and management. Can J Anaesth (1992) 0.75
Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature (1998) 24.69
Reminders to physicians from an introspective computer medical record. A two-year randomized trial. Ann Intern Med (1984) 15.06
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature (1996) 11.37
A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. Science (1998) 8.36
Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA (2001) 6.66
Serological analysis of the subgroup protein of rotavirus, using monoclonal antibodies. Infect Immun (1983) 5.85
Osteoarthritis: new insights. Part 2: treatment approaches. Ann Intern Med (2000) 5.58
Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates. Structure (2000) 5.57
Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell (1999) 4.97
A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis. Lancet (1995) 4.87
Energetics of the HIV gp120-CD4 binding reaction. Proc Natl Acad Sci U S A (2000) 4.44
A method for assessing drug therapy appropriateness. J Clin Epidemiol (1992) 4.36
The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis. Ann Intern Med (1995) 3.65
A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med (1996) 3.53
Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus. J Virol (2000) 3.52
Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein. J Virol (1997) 3.46
Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J Virol (1994) 3.43
Adverse drug events in high risk older outpatients. J Am Geriatr Soc (1997) 3.40
Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer. J Clin Oncol (1998) 3.38
Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs Health Care System: a randomized controlled trial. Diabetes Care (2001) 3.09
Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension (2001) 3.00
Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. J Virol (2000) 2.97
Comparison of cromoglycate (cromolyn) and theophylline in controlling symptoms of chronic asthma. A collaborative study. Lancet (1977) 2.90
Development of a stroke-specific quality of life scale. Stroke (1999) 2.87
Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins. J Virol (2000) 2.86
Probability analysis of variational crystallization and its application to gp120, the exterior envelope glycoprotein of type 1 human immunodeficiency virus (HIV-1). J Biol Chem (1999) 2.85
Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes? Am J Med (2000) 2.76
Outcomes of percutaneous endoscopic gastrostomy among older adults in a community setting. J Am Geriatr Soc (2000) 2.73
Theophylline. A "state of the art" review. Pharmacotherapy (1983) 2.62
Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc (2001) 2.61
Characterization of antibody responses elicited by human immunodeficiency virus type 1 primary isolate trimeric and monomeric envelope glycoproteins in selected adjuvants. J Virol (2006) 2.57
The natural history of dysphagia following a stroke. Dysphagia (1997) 2.51
The effect of automated calls with telephone nurse follow-up on patient-centered outcomes of diabetes care: a randomized, controlled trial. Med Care (2000) 2.42
Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers. J Virol (2001) 2.38
Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med (1999) 2.35
Rational modifications of HIV-1 envelope glycoproteins for immunogen design. Curr Pharm Des (2007) 2.35
Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis (2001) 2.34
Treatment failure after substitution of generic pancrelipase capsules. Correlation with in vitro lipase activity. JAMA (1990) 2.32
A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5. J Virol (1998) 2.28
Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution. J Virol (2000) 2.15
The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr Pulmonol (1995) 2.12
A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol (1994) 2.05
Intensive care services; a crisis of increasing expressed demand. Anaesthesia (1998) 2.02
Classifying general medicine readmissions. Are they preventable? Veterans Affairs Cooperative Studies in Health Services Group on Primary Care and Hospital Readmissions. J Gen Intern Med (1996) 1.89
CD4-independent binding of SIV gp120 to rhesus CCR5. Science (1997) 1.87
The impact of reading on physicians' nonadherence to recommended standards of medical care. Soc Sci Med (1985) 1.86
Adverse events after discontinuing medications in elderly outpatients. Arch Intern Med (1997) 1.79
Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 coreceptor. J Biol Chem (1999) 1.76
Visit-specific expectations and patient-centered outcomes: a literature review. Arch Fam Med (2001) 1.74
Measuring quality of life in a way that is meaningful to stroke patients. Neurology (1999) 1.74
Hyperspectral imaging: a novel approach for microscopic analysis. Cytometry (2001) 1.74
Use of monoclonal antibodies against two 75,000-molecular-weight glycoproteins specified by herpes simplex virus type 2 in glycoprotein identification and gene mapping. J Virol (1983) 1.73
Lack of association between patients' measured burden of disease and risk for hospital readmission. J Clin Epidemiol (1994) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Nontyphoid Salmonella bacteremia: age-related differences in clinical presentation, bacteriology, and outcome. Clin Infect Dis (1999) 1.65
Single gene control of postzygotic self-incompatibility in poke milkweed, Asclepias exaltata L. Genetics (2000) 1.64
Improved efficacy and safety of theophylline in the control of airways hyperreactivity. Pharmacol Ther (1982) 1.63
Measuring patient satisfaction for quality improvement. Med Care (1999) 1.59
The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian-human immunodeficiency virus-infected macaques. J Exp Med (1998) 1.59
Population differences in self-fertility in the "self-incompatible" milkweed Asclepias exaltata (Asclepiadaceae). Am J Bot (1999) 1.59
Stabilization of human immunodeficiency virus type 1 envelope glycoprotein trimers by disulfide bonds introduced into the gp41 glycoprotein ectodomain. J Virol (1998) 1.58
Inappropriate prescribing and health outcomes in elderly veteran outpatients. Ann Pharmacother (1997) 1.58
Paravertebral thoracic block-a reappraisal. Anaesthesia (1980) 1.57
Case management programs in primary care. J Gen Intern Med (1998) 1.57
Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic. Biochemistry (1999) 1.57
Automated computerized intensive care unit severity of illness measure in the Department of Veterans Affairs: preliminary results. SISVistA Investigators. Scrutiny of ICU Severity Veterans Health Sysyems Technology Architecture. Crit Care Med (2000) 1.56
Monitoring serum theophylline levels. Clin Pharmacokinet (1978) 1.54
Dose-dependent kinetics of theophylline disposition in asthmatic children. J Pediatr (1977) 1.52
Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke. Am Heart J (1998) 1.51
Disposition of theophylline after a single intravenous infusion of aminophylline. Am Rev Respir Dis (1978) 1.50
Predicting non-elective hospital readmissions: a multi-site study. Department of Veterans Affairs Cooperative Study Group on Primary Care and Readmissions. J Clin Epidemiol (2000) 1.48
A bioassay for topical and systemic effect of three inhaled corticosteroids. Clin Pharmacol Ther (1995) 1.46
Identification of quantitative trait loci influencing wood specific gravity in an outbred pedigree of loblolly pine. Genetics (1994) 1.44
Medication use by ambulatory elderly. An in-home survey. J Am Geriatr Soc (1986) 1.44
Prophylactic nitroglycerin infusion during noncardiac surgery does not reduce perioperative ischemia. Anesth Analg (1993) 1.43
Appropriateness of medication prescribing in ambulatory elderly patients. J Am Geriatr Soc (1994) 1.42
Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions. AIDS Res Hum Retroviruses (1998) 1.41
Comparison of double-lung jet ventilation and one-lung ventilation for thoracotomy. Eur J Anaesthesiol (2007) 1.41
The relation of product formulation to absorption of oral theophylline. N Engl J Med (1978) 1.40
Training assistants in cleft palate speech therapy in the developing world: a report. Cleft Palate J (1990) 1.40
Safety and efficacy of theophylline in children with asthma. J Pediatr (1992) 1.40
Analysis of the interaction of antibodies with a conserved enzymatically deglycosylated core of the HIV type 1 envelope glycoprotein 120. AIDS Res Hum Retroviruses (1998) 1.40
Knowledge and beliefs about cancer in a socioeconomically disadvantaged population. Cancer (1991) 1.36
Can bedside assessment reliably exclude aspiration following acute stroke? Age Ageing (1998) 1.36
Health status of individuals with mild stroke. Stroke (1997) 1.35
Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4. Biochemistry (2001) 1.35
Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis. Transpl Infect Dis (2002) 1.34
Antibiotic induced meningitis. J Neurol Neurosurg Psychiatry (1994) 1.33
Assessing inner-city patients' hospital experiences. A controlled trial of telephone interviews versus mailed surveys. Med Care (1997) 1.33
Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles. Virology (2007) 1.29
Current concepts. Slow-release theophylline rationale and basis for product selection. N Engl J Med (1983) 1.27
The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes. J Hosp Infect (2006) 1.27
The natural history of untreated hyperprolactinemia: a prospective analysis. J Clin Endocrinol Metab (1989) 1.25
Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997-2002. J Hosp Infect (2005) 1.24
Relationship of theophylline clearance to oral dosage in children with chronic asthma. J Pediatr (1977) 1.21
The role of physicians' knowledge and attitudes in effective diabetes management. Soc Sci Med (1984) 1.21
Use of automated telephone disease management calls in an ethnically diverse sample of low-income patients with diabetes. Diabetes Care (1999) 1.21
Guide to oral theophylline therapy for the treatment of chronic asthma. Am J Dis Child (1978) 1.20